Integration of artificial intelligence in lung cancer: Rise of the machine

The goal of oncology is to provide the longest possible survival outcomes with the therapeutics that are currently available without sacrificing patients' quality of life. In lung cancer, several data points over a pa-tient's diagnostic and treatment course are relevant to optimizing outcomes in the form of precision medi-cine, and artificial intelligence (AI) provides the opportunity to use available data from molecular information to radiomics, in combination with patient and tumor characteristics, to help clinicians provide individualized care. In doing so, AI can help create models to identify cancer early in diagnosis and deliver tailored therapy on the basis of available information, both at the time of diagnosis and in real time as they are undergoing treatment. The purpose of this review is to summarize the current literature in AI specific to lung cancer and how it applies to the multidisciplinary team taking care of these complex patients.

Automated summary

The goal of oncology is to provide the longest possible survival outcomes in lung cancer without sacrificing patients' quality of life. Artificial intelligence (AI) can utilize available data, including molecular information and radiomics, to help clinicians provide individualized care. AI can create models to identify cancer early in diagnosis and deliver tailored therapy based on available information, both at the time of diagnosis and in real time during treatment.